Direct comparison of TOfogliflozin and iPragliflozin on hyper-hypoglycemia using Continuous Glucose Monitoring system (TOP-CGM)
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000018265
- Lead Sponsor
- niversity of Occupational and Environmental Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Has hypersensitivity to tofogliflozin and ipragliflozin or any other excipient of them (2) With severe ketosis, diabetic coma, or precoma (3) With severe infection, pre or post-surgery, and serious trauma (4)Has arteriosclerotic disease (myocardial infarction, stroke and so on) and history of them (5) End-stage renal disease (ESRD) undergoing hemodialysis (6) With severe liver dysfunction (7) Has insulin therapy (8) Entered already with another clinical trials (9) Considered as inadequate by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method